GSK3B and Alzheimer disease: Emerging evidences suggest that overexpression of GSK3β as well as other kinases like Cdk5 plays a part in the progression of these neurodegenerative disorders like AD thus gaining a special interest in treating these disorders by employing therapeutic intervention in the form of specific inhibitors which can inactivate these kinases.